441 results on '"Kilpatrick, Trevor"'
Search Results
2. Mertk-expressing microglia influence oligodendrogenesis and myelin modelling in the CNS
3. Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis
4. Mouse microglia express unique miRNA-mRNA networks to facilitate age-specific functions in the developing central nervous system
5. High-efficiency pharmacogenetic ablation of oligodendrocyte progenitor cells in the adult mouse CNS
6. White matter tract conductivity is resistant to wide variations in paranodal structure and myelin thickness accompanying the loss of Tyro3: an experimental and simulated analysis
7. The therapeutic effect of GAS6 in remyelination is dependent upon Tyro3.
8. Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis.
9. Development of [18F]MIPS15692, a radiotracer with in vitro proof-of-concept for the imaging of MER tyrosine kinase (MERTK) in neuroinflammatory disease
10. Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study
11. Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome.
12. The oligodendrocyte-enriched orphan G protein-coupled receptor Gpr62 is dispensable for central nervous system myelination
13. The clinical profile of NMOSD in Australia and New Zealand
14. HLA-DRB1*15:01 and the MERTK Gene Interact to Selectively Influence the Profile of MERTK-Expressing Monocytes in Both Health and MS.
15. Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies.
16. Evidence for decreased copper associated with demyelination in the corpus callosum of cuprizone-treated mice.
17. The Patient‐Determined Disease Steps scale is not interchangeable with the Expanded Disease Status Scale in mild to moderate multiple sclerosis.
18. Changes in employment status over time in multiple sclerosis following a first episode of central nervous system demyelination, a Markov multistate model study.
19. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
20. The Tolerogenic Influence of Dexamethasone on Dendritic Cells Is Accompanied by the Induction of Efferocytosis, Promoted by MERTK.
21. EphA4 (Sek1) Receptor Tyrosine Kinase is Required for the Development of the Corticospinal Tract
22. Cell Death in the Schwann Cell Lineage and its Regulation by Neuregulin
23. Risk of a first clinical diagnosis of central nervous system demyelination in relation to human herpesviruses in the context of Epstein–Barr virus.
24. DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes.
25. A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort study.
26. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies
27. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations
28. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy
29. Achievements and obstacles of remyelinating therapies in multiple sclerosis
30. Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis.
31. Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity.
32. Higher consumption of ultra-processed foods and increased likelihood of central nervous system demyelination in a case-control study of Australian adults.
33. Dysequilibrium of the PTH-FGF23-vitamin D axis in relapsing remitting multiple sclerosis; a longitudinal study
34. Control of Visually Guided Saccades in Multiple Sclerosis: Disruption to Higher-Order Processes
35. A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis
36. A Functional and Neuropathological Testing Paradigm Reveals New Disability-Based Parameters and Histological Features for P0180–190-Induced Experimental Autoimmune Neuritis in C57BL/6 Mice
37. Axonally derived matrilin-2 induces proinflammatory responses that exacerbate autoimmune neuroinflammation
38. A Role for Galanin in Human and Experimental Inflammatory Demyelination
39. Suppressor of Cytokine Signaling 3 Limits Protection of Leukemia Inhibitory Factor Receptor Signaling against Central Demyelination
40. Fyn is an intermediate kinase that BDNF utilizes to promote oligodendrocyte myelination
41. Clinical impact of whole-genome sequencing in patients with early-onset dementia.
42. Gait stability reflects motor tracts damage at early stages of multiple sclerosis.
43. Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelination.
44. Therapeutic potential of LIF in multiple sclerosis
45. Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factor
46. Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis
47. Multiple sclerosis: Cognition and saccadic eye movements
48. Control of visually guided saccades in multiple sclerosis: Disruption to higher-order processes
49. Early predictors of visual and axonal outcomes after acute optic neuritis.
50. Role of Cytokines as Mediators and Regulators of Microglial Activity in Inflammatory Demyelination of the CNS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.